Formurex Presentation
•Download as PPT, PDF•
2 likes•622 views
Formurex is a contract research organization that provides drug formulation development services, analytical testing, GMP manufacturing, and stability studies to support clinical trials for pharmaceutical companies. Its mission is to advance medicine using cutting-edge drug formulation and delivery technologies. Services include preformulation studies, formulation development through various processes like granulation and coating, analytical testing through methods like HPLC and dissolution, and GMP manufacturing of tablets and capsules to support early-stage clinical trials.
Report
Share
Report
Share
![[object Object]](https://image.slidesharecdn.com/linkedin-formurex-presentation-1233709873148022-3/85/Formurex-Presentation-1-320.jpg)
![[object Object],[object Object],The Company & Values](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Sumary sedem formulacion ganador rafc
A continuación os anexo un summary del trabajo que nos permitio obtener un Accesit en el Concurso Cientifico Dr. Esteve 2009 de la Real Academia de Farmacia de Cat - España
Autores: Johnny Aguilar, Encarna G, Pilar P. de la Universidad de Barcelona Departamento de Tecnología Farmacéutica
Case study on change control in equipment
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
Hot melt extrusion
Hot melt extrusion is a process that converts raw materials into a uniform product by forcing it through a die under controlled conditions. It can be used to create solid dispersions of drugs to improve solubility and bioavailability. The key materials used are active pharmaceutical ingredients, polymers, and additives. Extruders provide mixing and agitation to uniformly disperse ingredients. The extruded material can be used to produce various dosage forms like tablets, pellets, and implants after characterization. Hot melt extrusion is an emerging drug delivery technique for solubility enhancement and modified drug release.
Parag semisolid
This document discusses scale up considerations for semi-solid manufacturing. It begins by defining semi-solid dosage forms as ointments, pastes, creams, emulsions, gels and foams that cling to the skin. The raw materials can include hydrocarbons, silicones, oils and water-based ingredients. Key unit operations include addition of components, heating, mixing, homogenization and filling. Process parameters like temperature, mixing rates and particle size must be controlled during scale up. Proper plant layout and equipment selection is also important for effective semi-solid manufacturing.
Step by Step process of Manufacturing of Pharmaceutical Medicine
A series of steps are followed by the manufacturing of pharmaceuticals for the manufacture of important drugs.
http://schwitzbiotech.ru/
PILOT PLANT DESIGN FOR TABLETS
This document provides an overview of the design and operations of a pharmaceutical pilot plant for tablet development. It discusses key considerations for scaling up processes like blending, granulation, milling, compression, and coating from small laboratory batches to production-sized equipment. The primary goal of the pilot plant is to ensure new tablet formulations can be efficiently, economically and consistently reproduced at full production scale. Features like air handling, equipment selection, and process parameters must be optimized during this scale-up to prevent issues like contamination, segregation, non-uniformity and other problems.
Single Pot Processor
This document provides an overview of single pot processing (SPP) for pharmaceutical granulation. SPP combines mixing, granulation, and drying steps into a single machine. It has several benefits over traditional granulation methods like reduced processing time and material handling. The document outlines the key features of SPP systems including integrated heating, drying mechanisms like vacuum and microwaves, and enhanced process control. It also presents a case study of using SPP for an effervescent product and discusses regulatory considerations for post-approval changes involving new equipment.
Recommended
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Sumary sedem formulacion ganador rafc
A continuación os anexo un summary del trabajo que nos permitio obtener un Accesit en el Concurso Cientifico Dr. Esteve 2009 de la Real Academia de Farmacia de Cat - España
Autores: Johnny Aguilar, Encarna G, Pilar P. de la Universidad de Barcelona Departamento de Tecnología Farmacéutica
Case study on change control in equipment
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
Hot melt extrusion
Hot melt extrusion is a process that converts raw materials into a uniform product by forcing it through a die under controlled conditions. It can be used to create solid dispersions of drugs to improve solubility and bioavailability. The key materials used are active pharmaceutical ingredients, polymers, and additives. Extruders provide mixing and agitation to uniformly disperse ingredients. The extruded material can be used to produce various dosage forms like tablets, pellets, and implants after characterization. Hot melt extrusion is an emerging drug delivery technique for solubility enhancement and modified drug release.
Parag semisolid
This document discusses scale up considerations for semi-solid manufacturing. It begins by defining semi-solid dosage forms as ointments, pastes, creams, emulsions, gels and foams that cling to the skin. The raw materials can include hydrocarbons, silicones, oils and water-based ingredients. Key unit operations include addition of components, heating, mixing, homogenization and filling. Process parameters like temperature, mixing rates and particle size must be controlled during scale up. Proper plant layout and equipment selection is also important for effective semi-solid manufacturing.
Step by Step process of Manufacturing of Pharmaceutical Medicine
A series of steps are followed by the manufacturing of pharmaceuticals for the manufacture of important drugs.
http://schwitzbiotech.ru/
PILOT PLANT DESIGN FOR TABLETS
This document provides an overview of the design and operations of a pharmaceutical pilot plant for tablet development. It discusses key considerations for scaling up processes like blending, granulation, milling, compression, and coating from small laboratory batches to production-sized equipment. The primary goal of the pilot plant is to ensure new tablet formulations can be efficiently, economically and consistently reproduced at full production scale. Features like air handling, equipment selection, and process parameters must be optimized during this scale-up to prevent issues like contamination, segregation, non-uniformity and other problems.
Single Pot Processor
This document provides an overview of single pot processing (SPP) for pharmaceutical granulation. SPP combines mixing, granulation, and drying steps into a single machine. It has several benefits over traditional granulation methods like reduced processing time and material handling. The document outlines the key features of SPP systems including integrated heating, drying mechanisms like vacuum and microwaves, and enhanced process control. It also presents a case study of using SPP for an effervescent product and discusses regulatory considerations for post-approval changes involving new equipment.
Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals Dr. Prashant L. Pingale GES's Sir Dr. M. S. Gosavi College of Pharmacy, Nashik
The document discusses pilot plant scale up for sterile veterinary parenteral solutions (SVPS). It defines key terms like plant, pilot plant, and scale up. The objectives and steps of scale up are outlined. The document describes the typical layout and working areas of a parenteral pilot plant, including warehousing, compounding, aseptic, and HEPA filter areas. It discusses evaluating laboratory studies and producing samples at the pilot plant scale. The document also covers different types of parenteral dosage forms that may be tested at a pilot plant, such as solutions, suspensions, emulsions, and dry powders.VxP Corporate Presentation CORP-A
VxP Pharma provides pharmaceutical development services and technical support for developing and producing pharmaceuticals, diagnostics, and drug-device combination products. It offers services across discovery, development, preclinical testing, formulation, manufacturing, and commercialization. VxP differentiates itself by having dedicated subject matter experts that focus on specific areas of development rather than generalists assigned to projects.
Pilot plant
This document provides an overview of pilot plant scale manufacturing of oral solid dosage forms like tablets and capsules. It discusses various unit operations involved like material handling, blending, granulation, drying, size reduction, compression, coating, and capsule filling. It explains that the purpose of a pharmaceutical pilot plant is to transform a lab-scale formula into a viable product by developing reliable manufacturing procedures. Key steps like blending, granulation, drying, milling and compression are described along with the equipment used in each step and important process parameters. Capsule manufacturing processes like dipping, drying, trimming and filling are also summarized.
Blending
This document provides an overview of blending as a unit operation in pharmaceutical manufacturing. It discusses the mechanisms of mixing, including convection, diffusion, and shear. Scale-up considerations are outlined, along with ways to minimize segregation. Methods for assessing powder blend uniformity include sampling and assay testing, with limitations of traditional sampling thieves discussed. Overall, blending is a critical step for ensuring uniform distribution of active and inactive ingredients in pharmaceutical products.
Common machinery of tablet manufacturing & Small scale & large scale manufact...
This document provides an overview of tablet manufacturing processes, including both small-scale and large-scale production. It discusses the common machinery used in tablet making, as well as the formulation, advantages, and disadvantages of tablets. Large-scale manufacturing is characterized by high production volumes, mechanization, and global markets. Challenges of large-scale production include less supervision and individualization. Small-scale manufacturing allows for closer supervision and personal attention. The document also describes pilot plants, which test production technologies at a smaller scale before commercialization.
Pilot plant scale up for tablets
This document discusses the design and scale up considerations of pilot plants for tablet manufacturing. It begins by defining a pilot plant and its significance in transforming a lab-scale formula into a viable product. The objectives of the pilot plant include producing stable dosage forms, identifying critical process features, and providing information to support larger scale production. The document then discusses various unit operations involved in tablet manufacturing like material handling, blending, granulation, drying, milling, blending, compression, and coating. It provides details on equipment selection and process parameters that must be considered during scale up for each unit operation to ensure quality and reproducibility at production scale.
TRIZ competition Part 2
The document discusses using TRIZ methodology to solve challenges faced by a selected industry regarding powdered product packaging. Specifically, the packaging of powder supplements causes powder to not pour out completely, which impacts ease of operation, measurement accuracy, and loss of substances. TRIZ analysis identifies the most suitable inventive principles as principle 15 and principle 3 to respectively improve ease of operation by changing the package shape and reduce loss of substance while maintaining the current shape.
Rapid mixer graqnulator
The Rapid Mixer Granulator is a multi-purpose machine that can blend powders, granulate wet masses, and produce effervescent and melt pelletized products using mechanical agitation and shearing forces. Validation of the Rapid Mixer Granulator involves qualification of installation, operation, and performance to verify it can produce granules within specified parameters. Tests are conducted at different mixing speeds and times to ensure content uniformity and granule consistency meet acceptance criteria.
Continuous Manufacturing of Tablets
This document discusses continuous manufacturing of tablets. It begins with an introduction to traditional batch tablet manufacturing and its limitations. Continuous manufacturing offers benefits like flexibility, less waste, and faster production. Key aspects of continuous tablet production lines include continuous blending, granulation, drying, compression, and coating using process analytical tools for real-time monitoring and control. Challenges to continuous manufacturing include integration of unit operations and the regulatory environment. Case studies presented show use of near infrared spectroscopy for content uniformity testing and effect of compaction pressure on tablet properties.
Validation of solid dosage form
The principal objective of dosage form design is to
achieve a predictable therapeutic response to a drug
included in a formulation which is capable of large scale
manufacture with reproducible product quality. To ensure
product quality, numerous features are required, like
chemical and physical stability, suitable preservation
against microbial contamination if appropriate,
uniformity of dose of drug, acceptability to users
including prescriber and patient, as well as suitable
packing, labeling, and validation1
.
Process validation establishes the flexibility and
constraints in the manufacturing process controls in the
attainment of desirable attributes in the drug product
while preventing undesirable properties. This is an
important concept, since it serves to support the
underlying definition of validation, which is a systematic
approach to identifying, measuring, evaluating,
documenting, and re-evaluating a series of critical steps in
the manufacturing process that require control to ensure
a reproducible final product.3
USFDA defined process validation as “establishing
documented evidence which provides high degree of
assurance that a specific process will consistently produce
a product meeting its pre determined specifications and
quality characteristics.”5
Solid dosage forms include tablets and capsules. The
manufacturing of solid dosage forms involves extensive
powder handling. The powder must be blended for
uniformity and converted into the dosage form either
through compression or encapsulation. Typical
requirements include weighing, blending,
mixing/granulation areas, compression/encapsulation
areas, and coating areas. 2
Despite the ongoing development of more sophisticated
solid drug delivery systems, tablets are still by far the
most prevalent solid dosage form. The emphasis will be
on the practical inspectional requirement, rather than on
a theoretical approach that does not reflect the
practicalities (and problems) encountered when
validating actual production operations.
A tablet is a pharmaceutical dosage form. It comprises a
mixture of active substances and excipients, usually in
powder form, pressed or compacted into a solid. The
excipients can include binders, glidants (flow aids) and
lubricants to ensure efficient tabletting; disintegrants to
promote tablet break-up in the digestive tract;
sweeteners or flavors to enhance taste; and pigments to
make the tablets visually attractive. A polymer coating is
often applied to make the tablet smoother and easier to
swallow, to control the release rate of the active
ingredient, to make it more resistant to the environment
(extending its shelf life), or to enhance the tablet's
appearance
Scaleup for capsules
1. This document discusses the scale up considerations for producing capsules in a pilot plant setting. It covers the various unit operations involved in capsule production like mixing, granulation, drying, lubrication, filling and finishing.
2. Key factors that must be considered during scale up for each unit operation are discussed, such as blender load, mixing time, drying temperature and airflow, amount of lubricant added, filling machine parameters, and polishing methods. Process controls and quality checks are also important to ensure quality and reproducibility.
3. Proper facility layout and environmental controls are required to maintain cGMP standards as the capsule production process is scaled up.
Quali and quant layout nitin
This document presents information on qualitative and quantitative plant layouts for semisolid dosage form manufacturing. It includes classifications of semisolid dosage forms, advantages, and requirements for external preparation and suppository plants based on Schedule M guidelines. Plant layout diagrams show designated areas for raw materials, manufacturing, filling, packaging, storage, and quality control. Specific requirements for topical preparation plants include manufacturing in an airlocked area with filtered air, exhaust systems, and temperature control.
Pharmaceutical Product Design
The document discusses aspects of product design for compounded pharmaceuticals. It outlines differences between industrial and pharmacy compounding in terms of development characteristics and regulatory environment. It emphasizes applying a quality by design approach to development through understanding a product's intended use and performance. A case study describes developing a ready-to-administer bupivacaine-sufentanil solution to improve post-operative analgesia safety.
Injection molding processing improvements
Actual application case study showing the advantages of using Silaplast in injection molded parts with processing issues
Ppt on dry powder inhalers
This document provides an overview of dry powder inhalers (DPIs), including their definition, types, characteristics, advantages, disadvantages, formulation considerations, common carriers used, manufacturing techniques, and characterization methods. DPIs deliver medication to the lungs in dry powder form and are commonly used to treat respiratory diseases like asthma. They have advantages over metered dose inhalers like not requiring breath holding and being propellant-free. Key aspects in developing effective DPIs include achieving targeted deposition, optimized aerosol generation, and operation at low inhalation flow rates. Common carriers in DPI formulations include lactose for its stability and compatibility. Micronization is often used to reduce drug particle size.
Pilot plant scale up techniques for solid dosage forms
This document discusses techniques for scaling up solid dosage form production from pilot plants. It covers key steps like material handling, blending, granulation, drying, particle size reduction, slugging, compression, coating and capsule filling. For each step, parameters important for process control are identified, such as equipment type, material properties, loading amounts, time, temperature and humidity settings. The goal of scaling up is to control these parameters to consistently produce quality products at larger volumes.
Pilot plant Techniques and Product consideration for liquid dosage forms.
CONTENTS:-
DEFINITION
INTRODUCTION
OBJECTIVES
LIQUID DOSAGE FORM
STEPS INVOLVED IN PILOT PLANT FOR ORAL LIQUID
GENERAL CONSIDERATION
Reporting responsibility
Personal requirements
Space requirements
Review of formula
Raw materials
Relevant processing equipments
Process evaluation
GMP consideration
Assurance
PILOT PLANT SCALE UP FOR SUSPENSION
PILOT PLANT SCALE UP FOR EMULSION
REFERENCES
pilot plant scale up techniques for tablets
The document discusses the scale up of tablet production from the laboratory scale to the pilot plant scale. It describes the various stages involved in tablet production such as material handling, dry blending, granulation, drying, milling, blending, compression, and coating. Scaling up from the lab scale to pilot plant scale requires adjustments to processing equipment, material handling procedures, blending times and speeds, drying methods, and compression equipment to optimize tablet properties such as content uniformity and hardness for production. The goal of the scale up process is to develop a reliable manufacturing process for producing viable tablet products.
Pilot plant tablets
Pilot plant scale-up techniques are used to transform lab-scale formulas into viable products for manufacturing. The objectives of building a pilot plant include examining the formula, equipment, production rates, and identifying critical process features. Various unit operations are involved in tablet production, including blending, granulation, drying, milling, compression, and coating. Careful consideration of parameters like material flow, temperature, and pressure is needed to successfully scale up from the pilot plant to full production.
Co processed excipient
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
BioTechnique ISPE-LA HEPA Presentation
This document summarizes a study comparing traditional microglass HEPA filters to newer PTFE HEPA filters in cleanroom HVAC systems. Testing in a test rig found the PTFE filters had 30-36% lower pressure drops than microglass filters, indicating potential energy savings. Simulation estimated the PTFE filters could reduce one facility's annual energy consumption by 9,350 kWh. Additional benefits of PTFE filters included longer lifetimes and recertification periods, reducing costs. Future studies were planned to further evaluate PTFE filter performance and energy savings.
Ispe nj ch_greendesignappliedcgmpbldgs
The document compares and contrasts green building design principles with cGMP (current Good Manufacturing Practices) requirements for pharmaceutical buildings. Some key differences include green buildings prioritizing energy efficiency and minimizing environmental impact, while cGMP focuses on ensuring product quality and purity through strict cleanliness standards, material traceability, specific HVAC and utility requirements. Both aim for high quality and reliability, but cGMP regulations take precedence in pharmaceutical facilities and add significantly to costs. Administrative and engineering practices must also account for longer FDA approval timelines under cGMP.
More Related Content
What's hot
Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals Dr. Prashant L. Pingale GES's Sir Dr. M. S. Gosavi College of Pharmacy, Nashik
The document discusses pilot plant scale up for sterile veterinary parenteral solutions (SVPS). It defines key terms like plant, pilot plant, and scale up. The objectives and steps of scale up are outlined. The document describes the typical layout and working areas of a parenteral pilot plant, including warehousing, compounding, aseptic, and HEPA filter areas. It discusses evaluating laboratory studies and producing samples at the pilot plant scale. The document also covers different types of parenteral dosage forms that may be tested at a pilot plant, such as solutions, suspensions, emulsions, and dry powders.VxP Corporate Presentation CORP-A
VxP Pharma provides pharmaceutical development services and technical support for developing and producing pharmaceuticals, diagnostics, and drug-device combination products. It offers services across discovery, development, preclinical testing, formulation, manufacturing, and commercialization. VxP differentiates itself by having dedicated subject matter experts that focus on specific areas of development rather than generalists assigned to projects.
Pilot plant
This document provides an overview of pilot plant scale manufacturing of oral solid dosage forms like tablets and capsules. It discusses various unit operations involved like material handling, blending, granulation, drying, size reduction, compression, coating, and capsule filling. It explains that the purpose of a pharmaceutical pilot plant is to transform a lab-scale formula into a viable product by developing reliable manufacturing procedures. Key steps like blending, granulation, drying, milling and compression are described along with the equipment used in each step and important process parameters. Capsule manufacturing processes like dipping, drying, trimming and filling are also summarized.
Blending
This document provides an overview of blending as a unit operation in pharmaceutical manufacturing. It discusses the mechanisms of mixing, including convection, diffusion, and shear. Scale-up considerations are outlined, along with ways to minimize segregation. Methods for assessing powder blend uniformity include sampling and assay testing, with limitations of traditional sampling thieves discussed. Overall, blending is a critical step for ensuring uniform distribution of active and inactive ingredients in pharmaceutical products.
Common machinery of tablet manufacturing & Small scale & large scale manufact...
This document provides an overview of tablet manufacturing processes, including both small-scale and large-scale production. It discusses the common machinery used in tablet making, as well as the formulation, advantages, and disadvantages of tablets. Large-scale manufacturing is characterized by high production volumes, mechanization, and global markets. Challenges of large-scale production include less supervision and individualization. Small-scale manufacturing allows for closer supervision and personal attention. The document also describes pilot plants, which test production technologies at a smaller scale before commercialization.
Pilot plant scale up for tablets
This document discusses the design and scale up considerations of pilot plants for tablet manufacturing. It begins by defining a pilot plant and its significance in transforming a lab-scale formula into a viable product. The objectives of the pilot plant include producing stable dosage forms, identifying critical process features, and providing information to support larger scale production. The document then discusses various unit operations involved in tablet manufacturing like material handling, blending, granulation, drying, milling, blending, compression, and coating. It provides details on equipment selection and process parameters that must be considered during scale up for each unit operation to ensure quality and reproducibility at production scale.
TRIZ competition Part 2
The document discusses using TRIZ methodology to solve challenges faced by a selected industry regarding powdered product packaging. Specifically, the packaging of powder supplements causes powder to not pour out completely, which impacts ease of operation, measurement accuracy, and loss of substances. TRIZ analysis identifies the most suitable inventive principles as principle 15 and principle 3 to respectively improve ease of operation by changing the package shape and reduce loss of substance while maintaining the current shape.
Rapid mixer graqnulator
The Rapid Mixer Granulator is a multi-purpose machine that can blend powders, granulate wet masses, and produce effervescent and melt pelletized products using mechanical agitation and shearing forces. Validation of the Rapid Mixer Granulator involves qualification of installation, operation, and performance to verify it can produce granules within specified parameters. Tests are conducted at different mixing speeds and times to ensure content uniformity and granule consistency meet acceptance criteria.
Continuous Manufacturing of Tablets
This document discusses continuous manufacturing of tablets. It begins with an introduction to traditional batch tablet manufacturing and its limitations. Continuous manufacturing offers benefits like flexibility, less waste, and faster production. Key aspects of continuous tablet production lines include continuous blending, granulation, drying, compression, and coating using process analytical tools for real-time monitoring and control. Challenges to continuous manufacturing include integration of unit operations and the regulatory environment. Case studies presented show use of near infrared spectroscopy for content uniformity testing and effect of compaction pressure on tablet properties.
Validation of solid dosage form
The principal objective of dosage form design is to
achieve a predictable therapeutic response to a drug
included in a formulation which is capable of large scale
manufacture with reproducible product quality. To ensure
product quality, numerous features are required, like
chemical and physical stability, suitable preservation
against microbial contamination if appropriate,
uniformity of dose of drug, acceptability to users
including prescriber and patient, as well as suitable
packing, labeling, and validation1
.
Process validation establishes the flexibility and
constraints in the manufacturing process controls in the
attainment of desirable attributes in the drug product
while preventing undesirable properties. This is an
important concept, since it serves to support the
underlying definition of validation, which is a systematic
approach to identifying, measuring, evaluating,
documenting, and re-evaluating a series of critical steps in
the manufacturing process that require control to ensure
a reproducible final product.3
USFDA defined process validation as “establishing
documented evidence which provides high degree of
assurance that a specific process will consistently produce
a product meeting its pre determined specifications and
quality characteristics.”5
Solid dosage forms include tablets and capsules. The
manufacturing of solid dosage forms involves extensive
powder handling. The powder must be blended for
uniformity and converted into the dosage form either
through compression or encapsulation. Typical
requirements include weighing, blending,
mixing/granulation areas, compression/encapsulation
areas, and coating areas. 2
Despite the ongoing development of more sophisticated
solid drug delivery systems, tablets are still by far the
most prevalent solid dosage form. The emphasis will be
on the practical inspectional requirement, rather than on
a theoretical approach that does not reflect the
practicalities (and problems) encountered when
validating actual production operations.
A tablet is a pharmaceutical dosage form. It comprises a
mixture of active substances and excipients, usually in
powder form, pressed or compacted into a solid. The
excipients can include binders, glidants (flow aids) and
lubricants to ensure efficient tabletting; disintegrants to
promote tablet break-up in the digestive tract;
sweeteners or flavors to enhance taste; and pigments to
make the tablets visually attractive. A polymer coating is
often applied to make the tablet smoother and easier to
swallow, to control the release rate of the active
ingredient, to make it more resistant to the environment
(extending its shelf life), or to enhance the tablet's
appearance
Scaleup for capsules
1. This document discusses the scale up considerations for producing capsules in a pilot plant setting. It covers the various unit operations involved in capsule production like mixing, granulation, drying, lubrication, filling and finishing.
2. Key factors that must be considered during scale up for each unit operation are discussed, such as blender load, mixing time, drying temperature and airflow, amount of lubricant added, filling machine parameters, and polishing methods. Process controls and quality checks are also important to ensure quality and reproducibility.
3. Proper facility layout and environmental controls are required to maintain cGMP standards as the capsule production process is scaled up.
Quali and quant layout nitin
This document presents information on qualitative and quantitative plant layouts for semisolid dosage form manufacturing. It includes classifications of semisolid dosage forms, advantages, and requirements for external preparation and suppository plants based on Schedule M guidelines. Plant layout diagrams show designated areas for raw materials, manufacturing, filling, packaging, storage, and quality control. Specific requirements for topical preparation plants include manufacturing in an airlocked area with filtered air, exhaust systems, and temperature control.
Pharmaceutical Product Design
The document discusses aspects of product design for compounded pharmaceuticals. It outlines differences between industrial and pharmacy compounding in terms of development characteristics and regulatory environment. It emphasizes applying a quality by design approach to development through understanding a product's intended use and performance. A case study describes developing a ready-to-administer bupivacaine-sufentanil solution to improve post-operative analgesia safety.
Injection molding processing improvements
Actual application case study showing the advantages of using Silaplast in injection molded parts with processing issues
Ppt on dry powder inhalers
This document provides an overview of dry powder inhalers (DPIs), including their definition, types, characteristics, advantages, disadvantages, formulation considerations, common carriers used, manufacturing techniques, and characterization methods. DPIs deliver medication to the lungs in dry powder form and are commonly used to treat respiratory diseases like asthma. They have advantages over metered dose inhalers like not requiring breath holding and being propellant-free. Key aspects in developing effective DPIs include achieving targeted deposition, optimized aerosol generation, and operation at low inhalation flow rates. Common carriers in DPI formulations include lactose for its stability and compatibility. Micronization is often used to reduce drug particle size.
Pilot plant scale up techniques for solid dosage forms
This document discusses techniques for scaling up solid dosage form production from pilot plants. It covers key steps like material handling, blending, granulation, drying, particle size reduction, slugging, compression, coating and capsule filling. For each step, parameters important for process control are identified, such as equipment type, material properties, loading amounts, time, temperature and humidity settings. The goal of scaling up is to control these parameters to consistently produce quality products at larger volumes.
Pilot plant Techniques and Product consideration for liquid dosage forms.
CONTENTS:-
DEFINITION
INTRODUCTION
OBJECTIVES
LIQUID DOSAGE FORM
STEPS INVOLVED IN PILOT PLANT FOR ORAL LIQUID
GENERAL CONSIDERATION
Reporting responsibility
Personal requirements
Space requirements
Review of formula
Raw materials
Relevant processing equipments
Process evaluation
GMP consideration
Assurance
PILOT PLANT SCALE UP FOR SUSPENSION
PILOT PLANT SCALE UP FOR EMULSION
REFERENCES
pilot plant scale up techniques for tablets
The document discusses the scale up of tablet production from the laboratory scale to the pilot plant scale. It describes the various stages involved in tablet production such as material handling, dry blending, granulation, drying, milling, blending, compression, and coating. Scaling up from the lab scale to pilot plant scale requires adjustments to processing equipment, material handling procedures, blending times and speeds, drying methods, and compression equipment to optimize tablet properties such as content uniformity and hardness for production. The goal of the scale up process is to develop a reliable manufacturing process for producing viable tablet products.
Pilot plant tablets
Pilot plant scale-up techniques are used to transform lab-scale formulas into viable products for manufacturing. The objectives of building a pilot plant include examining the formula, equipment, production rates, and identifying critical process features. Various unit operations are involved in tablet production, including blending, granulation, drying, milling, compression, and coating. Careful consideration of parameters like material flow, temperature, and pressure is needed to successfully scale up from the pilot plant to full production.
Co processed excipient
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
What's hot (20)
Common machinery of tablet manufacturing & Small scale & large scale manufact...
Common machinery of tablet manufacturing & Small scale & large scale manufact...
Pilot plant scale up techniques for solid dosage forms
Pilot plant scale up techniques for solid dosage forms
Pilot plant Techniques and Product consideration for liquid dosage forms.
Pilot plant Techniques and Product consideration for liquid dosage forms.
Viewers also liked
BioTechnique ISPE-LA HEPA Presentation
This document summarizes a study comparing traditional microglass HEPA filters to newer PTFE HEPA filters in cleanroom HVAC systems. Testing in a test rig found the PTFE filters had 30-36% lower pressure drops than microglass filters, indicating potential energy savings. Simulation estimated the PTFE filters could reduce one facility's annual energy consumption by 9,350 kWh. Additional benefits of PTFE filters included longer lifetimes and recertification periods, reducing costs. Future studies were planned to further evaluate PTFE filter performance and energy savings.
Ispe nj ch_greendesignappliedcgmpbldgs
The document compares and contrasts green building design principles with cGMP (current Good Manufacturing Practices) requirements for pharmaceutical buildings. Some key differences include green buildings prioritizing energy efficiency and minimizing environmental impact, while cGMP focuses on ensuring product quality and purity through strict cleanliness standards, material traceability, specific HVAC and utility requirements. Both aim for high quality and reliability, but cGMP regulations take precedence in pharmaceutical facilities and add significantly to costs. Administrative and engineering practices must also account for longer FDA approval timelines under cGMP.
Ispe sf ch_gamp
The document discusses GAMP (Good Automated Manufacturing Practices), an organization that provides guidance for validation of automated systems used in regulated industries. It summarizes GAMP's objectives to achieve compliance through existing industry practices efficiently. It also describes GAMP's structure, including its council, committees, special interest groups and links to regulatory agencies. Finally, it provides an overview of GAMP's guidance documents, principles and validation approaches.
Water for ap is amsavel
The document discusses water purification for pharmaceutical use. It describes various types of water (e.g. purified water, highly purified water, water for injection) and their specifications. The purification process involves multiple validation phases to demonstrate the system can consistently produce water meeting specifications. Quality must be controlled during production, storage and distribution to prevent microbial or chemical contamination.
ICH Q 10 guidline
This document presents an overview of the Pharmaceutical Quality Systems (ICH Q10) guideline. ICH Q10 establishes a quality management system model for the pharmaceutical industry and was intended to help companies comply with Good Manufacturing Practices. The objectives of ICH Q10 are to achieve product realization, establish control, and facilitate continual improvement. ICH Q10 also discusses management responsibility, risk management, challenges of implementing the new system, and the relationship between ICH Q10 and other quality standards like GMP.
2013 Guide to a Contamination Free Cleanroom
This document provides information about cleanroom gloves, finger cots, and wipers. It discusses the various materials used to make cleanroom gloves including vinyl, latex, nitrile, and chloroprene. It describes the manufacturing process for cleanroom gloves which involves dipping, rinsing, vulcanizing, chlorination, cleaning and testing, and packaging. It also discusses attributes of different glove materials, sizing, length, texture, and packaging of gloves. The document provides similar information about finger cots and wipers that are used in cleanroom environments.
Pharmaceutical water
The document discusses pharmaceutical water systems. It begins by defining various types of high purity water like purified water, sterile purified water, water for injection, and sterile water for injection. It then discusses how purified water and water for injection are produced, typically through processes like distillation, ion exchange, or reverse osmosis. The document also covers considerations for storing and distributing high purity water, such as using stainless steel materials, minimizing dead legs, and sanitizing distribution systems through heat, ozone, or chemicals. Finally, it presents different options for setting up hot and cold storage and distribution systems.
Soft gelatin capsule
This document discusses soft gelatin capsules. Soft gelatin capsules have soft, gelatin shells that contain liquid or semisolid fill materials. They are formed, filled, and sealed in a single operation using either a droplet or pressing method. Soft gelatin capsules offer advantages over hard capsules like improved bioavailability and enhanced stability. The shells are made of gelatin, plasticizers, preservatives, colors and flavors. Soft gelatin capsules can be used orally or for other routes of administration.
Water Part1
The document discusses water systems and purification methods used in pharmaceutical manufacturing. It introduces different grades of water quality (e.g. purified water, water for injections) and their applications. Common water contaminants are outlined. Water purification systems may use various pretreatment steps and methods like filtration, softening, and disinfection. Proper design, operation, and maintenance of water systems is required to reliably produce water of the necessary quality.
Water Part2
This document discusses water purification and engineering for pharmaceutical use. It examines requirements for water treatment systems, storage and distribution, sampling and testing, and sanitization. Key points include selecting suitable contact materials, maintaining turbulent flow and avoiding dead legs to control biocontamination, and using techniques like continuous circulation, UV radiation, and periodic sanitization to prevent microbial growth.
Water Part3
The document provides guidance on inspecting water purification systems used in pharmaceutical applications, outlining key areas to review such as schematics, sample procedures, test results, maintenance logs, and validation documents, and recommends verifying systems by walking through and checking components, instrumentation, and records.
Presentation: Cleaning and Contamination Control: A regulatory perspective
The document discusses regulatory perspectives on cleaning and contamination control from an inspector of the Therapeutic Goods Administration in Australia. It covers current GMP requirements, future GMP developments, observed good practices in contamination control, and common deficiencies found in inspections. Some key points include that contamination control strategies should be risk-based and rely on quality risk management principles. Inspections often find deficiencies in assessing intrinsic hazards of products and processes, in the design of facilities and equipment to control contamination risks, and in validation of cleaning processes.
A Practical Approach to Implementing ICH Q10 Pharmaceutical Quality Systems
The document provides an overview of implementing a pharmaceutical quality system according to ICH Q10 guidelines. It discusses establishing the foundation through following procedures and defining a quality policy. It then outlines a "simple process" to implement key elements like quality objectives, continual improvement plans, and management reviews. The goal is to enhance quality and facilitate innovation using a risk-based approach throughout the product lifecycle.
ICH Q10 Pharmaceutical Quaity System
The document summarizes ICH Q10, which provides a harmonized model for a pharmaceutical quality system throughout the lifecycle of a product. It describes the contents and sections of ICH Q10, including management responsibility, continual improvement of process performance and product quality, and continual improvement of the pharmaceutical quality system. The goal is to establish an effective quality management system for the pharmaceutical industry and enhance the quality and availability of medicines.
Gmp qa and doccumentation by kailash vilegave
Good Manufacturing Practices.
Basic rules of GMP
Various aspects of GMP.
How do GMP change.
Comparison of GMP.
Quality assurance
Principles of QA
Functions of QA department.
Documentation
Importance of documentation of records
Important areas of documentation
Components of documentation
GMP Training: Handling of deviation
This document discusses handling deviations from standard operating procedures in quality management systems. It defines a deviation as any departure from approved instructions or established standards. Deviations are classified as either planned or unplanned. Unplanned deviations require investigation to determine the root cause and implement corrective and preventive actions. The investigation process involves documenting the event, taking immediate action, analyzing the root cause, implementing corrective actions, and evaluating effectiveness. Guidelines such as ICH Q7 provide requirements for deviation handling, investigation, and corrective action to prevent future deviations.
GMP AND cGMP CONSIDERATIONS
The document discusses Good Manufacturing Practices (GMP) and current Good Manufacturing Practices (cGMP). It defines GMP as ensuring products are consistently manufactured and controlled according to quality standards for their intended use. cGMP emphasizes that expectations are dynamic and evolve over time. The document outlines several key GMP considerations including organization and personnel qualifications, facility and equipment design, production and process control, packaging and labeling, handling and distribution, and documentation through records and reports.
GMP good manufacturing practice)
This document provides definitions and descriptions related to Good Manufacturing Practices (GMP) regulations for pharmaceutical manufacturing. It defines key terms like active pharmaceutical ingredient, batch, and validation. It describes GMP requirements for facilities, equipment, documentation, personnel training, hygiene practices, and prevention of cross-contamination. The goal of GMP is to ensure manufactured products are safe, pure and effective.
Cleanroom clothing - Why, what and how?
Cleanroom clothing is worn to protect cleanroom environments and products from human contamination. People are the largest source of particles in cleanrooms, shedding skin cells and microbes. Cleanroom clothing must filter these contaminants and include head covers, body suits, gloves, boots, and face masks appropriate for the cleanroom class. The clothing is donned in a changing room process to minimize contamination entering the cleanroom.
EU GMP Annex1 Review
What is likely to go into the revised Annex 1, including:
Terminal sterilisation vs aseptic processing
WFI produced by reverse osmosis
Guidance for media simulation trials
This remains speculative
Viewers also liked (20)
Presentation: Cleaning and Contamination Control: A regulatory perspective
Presentation: Cleaning and Contamination Control: A regulatory perspective
A Practical Approach to Implementing ICH Q10 Pharmaceutical Quality Systems
A Practical Approach to Implementing ICH Q10 Pharmaceutical Quality Systems
Similar to Formurex Presentation
Xcelience New
Xcelience specializes in early preformulation, formulation and clinical supplies. Early drug development made easy!
Xcelience new
Xcelience is a contract research organization that has provided formulation development and clinical trial manufacturing solutions for pharmaceutical companies since 1997. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. Core services include: API Characterization, Analytical Development and Stability Services, Formulation Development, and Clinical Trial Manufacturing, Packaging and Labeling. For more detailed information about Xcelience, visit www.xcelience.com
Diteba Research Laboratories Corporate Capabilities
Diteba is a cGMP/GLP pharmaceutical laboratory located near Toronto, Canada that offers analytical R&D services including method development and validation, bioanalytical testing, quality control release testing, stability testing, and in vitro release testing. The company has over 10,000 square feet of laboratory space equipped with state-of-the-art instrumentation. Diteba's team of senior scientists have extensive experience across various therapeutic areas and analytical techniques.
In Vitro Drug Product Performance.ppt
This document discusses in vitro drug product performance characterization and dissolution testing of solid oral dosage forms. It describes the importance of in vitro testing in predicting in vivo drug absorption and performance. The key factors that can affect drug dissolution are described, including drug substance properties, formulation composition, manufacturing processes, and test conditions. Common dissolution apparatus, media, and acceptance tolerances used in testing immediate release solid oral drug products are also summarized.
In Vitro Drug Product Performance.ppt
1. The document discusses in vitro characterization of solid oral drug products, focusing on factors that affect drug dissolution and release from these products. It covers the importance of dissolution testing, types of solid oral dosage forms, and factors related to drug substances, formulations, manufacturing processes, and dissolution test conditions.
2. Dissolution tests are described as important for evaluating drug product performance and predicting in vivo absorption. Key aspects of dissolution testing covered include test apparatus, media, and acceptance tolerances for immediate release products.
3. The factors discussed indicate that drug dissolution is a complex, multifactorial process influenced by properties of the active drug, dosage form design, and test conditions. Careful consideration of these factors is important
Solid dispersion
SOLID DISPERSION
Definition: The technology is the science of dispersing one or more active ingredients in an inert matrix in the solid stage.
Need of solid dispersion:
Increases Oral bioavailability of a drug
Increased dissolution rate.
Enhanced release of drugs from ointment.
Improved the solubility & stability.
The concept of solid dispersion was originally proposed by Sekiguchi & obi.
Increasing the dissolution, absorption & therapeutic efficacy of drugs in dosage forms.
Increasing solubility in water.
Improving the oral absorption and bioavailability of BCS Class II drugs.
Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piro...
The solubility behavior of drugs remains one of the most exigent aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Among all the newly discovered chemical entities, about 40 45 drugs fail to reach market due to their poor water solubility. Because of solubility problem, bioavailability of drugs gets affected and hence solubility enhancement becomes necessary. In present study the attempts have been made to increase the dissolution of BCS class 2 drug Piroxicam using hydrophilic polymers namely polyethylene glycol PEG 6000 and sodium lauryl sulphate as a surfactant by using solid dispersion technique. In solid dispersion microwave induced solid dispersion and conventional fusion method is compared. Drug polymer complex was prepared using batch method. Maximum dissolution rate was obtained of the complex prepared from Piroxicam PEG6000 SLS . A successful solubility enhancement of drug complex was confirmed by taking drug release in phosphate buffer pH 6.8. The drug was characterized according to different compendial methods, on the basis of identification by UV spectroscopy, organoleptic properties and other tests. After that among the all formulation batches, solid dispersion F16 was selected for further tablet formulation batches, nine formulations were developed and studied. The values of pre compression parameters was evaluated, results were within prescribed limits and indicated good free flowing properties. The data obtained of post compression parameters such as weight variation, hardness, friability, wetting time, water absorption ratio, content uniformity, disintegration time and dissolution was found to superior over conventional formulation. The F9 batch with disintegrating time 10 ± 0.52 second and dissolution 93.20 ± 0.61 was selected as optimized formulation and was found superior over other formulation. Batch F9 was also subjected to stability studies for three months and was tested for its disintegrating time, drug contents and dissolution behavior monthly. F9 formulation after stability study was found to be stable. Mr. Yennuwar Dhiresh Pramod | Mr. Sujit Kakade | Mrs. Trusha Shangrapawar | Dr. Ashok Bhosale "Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piroxicam using Solid Dispersion Technique" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-5 , August 2022, URL: https://www.ijtsrd.com/papers/ijtsrd50422.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/50422/formulation-development-and-evaluation-of-fast-disintegrating-tablet-of-piroxicam-using-solid-dispersion-technique/mr-yennuwar-dhiresh-pramod
Presentation Of Capabilities Elf
Penn Pharma provides pharmaceutical development, manufacturing, packaging, and consulting services. Their capabilities include formulation development, analytical testing, clinical trial supply, commercial manufacturing, and QP certification. They have facilities for tablets, capsules, liquids, and other dosage forms. Penn Pharma offers a full range of integrated services to support customers from pre-clinical development through commercialization.
High Quality Integrated Drug R&D Services
End-to-end services and solutions covering the entire spectrum of preclinical biopharmaceutical R&D. Supporting everything from target discovery, candidate development, preclinical screening and drug safety evaluation through IND submission. https://www.medicilon.com/about-medicilon/
Dissolution
This document discusses dissolution, which is the process by which a solid substance solubilizes in a solvent. It defines dissolution rate and introduces the Noyes-Whitney equation. It then describes 7 types of dissolution apparatus used in compendial methods for testing drug dissolution, including rotating basket, paddle, reciprocating cylinder, and flow through cell. Key factors that affect dissolution rate are also outlined, such as drug properties, formulation components, processing methods, apparatus parameters, and test conditions.
Xcelience Formulation Development
Partnering with a specialist like Xcelience for early phase small molecule development can accelerate timelines and reduce product risk.
Core Rx Presentation
CoreRx is a contract pharmaceutical development and manufacturing organization that helps get you into the clinic faster, providing a complete spectrum of cGMP solutions for pharmaceutical dosage form development. Our wide range of support services, extensive instrumentation and rigorous quality systems provide timely results communicated in a clear, efficient and consistent manner.
Core Rx Presentation
CoreRx is a dosage form development company specializing in preformulation, formulation development, analytical development, clinical manufacturing, and commercial manufacturing. It has experienced professionals and state-of-the-art facilities. CoreRx focuses on client satisfaction through effective communication, flexibility, speed, and high quality systems. It offers a range of services from preformulation to stability studies to meet clients' drug development needs.
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Preformulation/pharmaceutical preformulation
This document provides an overview of preformulation studies for a new drug. It discusses characterizing the physical and chemical properties of the drug molecule to develop a safe, effective, and stable dosage form. Key aspects of preformulation studies that are described include salt formation, prodrug design, polymorphism, crystallinity, hygroscopicity, particle characterization, bulk density, powder flow properties, solubility analysis, stability analysis, and drug-excipient compatibility testing. The goal of preformulation is to obtain essential information to guide formulation development and design robust evaluation of the new drug candidate.
Latitude Pharmaceuticals Overview
Latitude Pharmaceuticals is a formulation development company that has been in business for over 13 years. They have extensive experience formulating insoluble and unstable active pharmaceutical ingredients and have completed over 700 projects for more than 200 clients. Latitude utilizes various proprietary drug delivery platforms and formulation techniques to develop a wide range of drug dosage forms, including solutions, suspensions, liposomes, and more. Their goal is to provide clients with customized formulation solutions and translate products into clinical development.
Nextar presentation
Nextar is an outsourcing company located in Israel that provides integrated contract drug development and manufacturing services. They have over 35 employees working in state-of-the-art laboratories and clean rooms. Nextar has cGMP, GLP, ISO 13485, and ISO 9001 certifications. Their services include formulation development, analytical testing, custom chemical synthesis, and GMP manufacturing for clinical trials. They have successfully completed over 570 projects for 120 customers.
Stability_Considerations_In_Formulation_Development.ppt
The document discusses the importance of stability considerations in pharmaceutical development. It states that stability is a key attribute and integral part of drug and dosage form development. The aim of pharmaceutical development is to design stable products and control factors preventing quality and stability issues. Stability evaluations start early in drug development and cover various stages. The physical state of drugs can influence stability, dissolution, and bioavailability. Factors like polymorphism, hydration, and processing need to be controlled. Excipient selection and manufacturing processes also impact stability and should be considered during formulation development.
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
Location:- GIDC Estate Ankleswar
393002, Dist. Bharuch ,Gujrat India
Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better supportpeople’s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.
About Zentiva’s Ankleshwar site
Established in 1987, the Ankleshwar manufacturing site has a chemistry and biotechnology development center, and manufactures both intermediates and pharmaceutical formulations. A large producer of tablets, the Ankleshwar site manufactures more than 6 billion tablets annually.
Mission &Values:-
Zentiva is a leading developer and supplier of high-quality affordable prescription medicines and consumer brands. As Zentiva grows more people get the medicine they need. Our business is built on trust and responsibility with the patient at the heart of everything we do. Zentiva has established 6 shared SuperpowerZ which frame the values and behaviours we expect of our team and how we will build a healthy business that we can all be proud of.
TABLET-SECTION
Tablet:-
A tablet is a mixture of active substances and excipients, usually in powder form, pressed or compacted into a solid. The excipients include binders, Glidants (flow aids) and lubricants to ensure efficient tabletting, disintegrates to ensure that the tablet breaks up in the digestive tract; sweeteners or flavors to mask the taste of bad-tasting active ingredients; and pigments to make uncoated tablets visually attractive. A coating may be applied to hide the taste of the tablet's components, to make the tablet smoother and easier to swallow, and to make it more resistant to the environment, extending its shelf life.
Advantage
• Production aspect
Large scale production at lowest cost
Easiest and cheapest to package and ship
High stability
• User aspect (doctor, pharmacist, patient)
Easy to handling.
Lightest and most compact.
Greatest dose precision & least content variability.
Coating can mark unpleasant tastes & improve pt. acceptability.
PHARMACEUTICAL PRODUCT BY ZENTIVA PHARMACEUTICAL PVT.LTD:-
1. Avil -25 mg
2. Trental-400
3. Paracetamol-500mg
4. Ramilich-( 5, 25mg)
5. Ramipril-25mg
6. Zuglimate-500mg
7. Clopidogrel-75mg
8. Metformin-100mg
QUALITY CONTROL AND QUALITY ASSUARANCE
Quality control is the part of GMP that deals with sampling, specification, and testing, as well as organisation, documentation, and release procedures to ensure that necessary and
Sitec Presentation 140915
Sitec Labs provides contract research services with the vision to be a global leader in the industry through innovation and quality excellence. Their mission is to support drug discovery and development, ensure compliance with quality standards, and be a long-term trusted partner. They have over 350 staff members across two facilities totaling 75,000 square feet. Services include analytical research, impurity synthesis, bioavailability/bioequivalence studies, and regulatory compliance.
Similar to Formurex Presentation (20)
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piro...
Formulation, Development and Evaluation of Fast Disintegrating Tablet of Piro...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Stability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.ppt
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
Recently uploaded
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
Leaders who possess self-awareness deeply understand their emotions, strengths, and weaknesses.
-- June 2024 is National Volunteer Month --
Check out our June display of books on voluntary organisations
Easily Verify Compliance and Security with Binance KYC
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
Best Forex Brokers Comparison in INDIA 2024
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
Structural Design Process: Step-by-Step Guide for Buildings
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
一比一原版新西兰奥塔哥大学毕业证（otago毕业证）如何办理
一模一样【微信：A575476】【新西兰奥塔哥大学毕业证（otago毕业证）成绩单Offer】【微信：A575476】（留信学历认证永久存档查询）采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信：A575476】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信：A575476】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
→ 【关于价格问题（保证一手价格）
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：可来公司面谈，可签订合同，会陪同客户一起到教育部认证窗口递交认证材料，客户在教育部官方认证查询网站查询到认证通过结果后付款，不成功不收费！
Mastering B2B Payments Webinar from BlueSnap
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
Industrial Tech SW: Category Renewal and Creation
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
Digital Marketing with a Focus on Sustainability
Digital Marketing best practices including influencer marketing, content creators, and omnichannel marketing for Sustainable Brands at the Sustainable Cosmetics Summit 2024 in New York
Company Valuation webinar series - Tuesday, 4 June 2024
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSSBest practices for project execution and delivery
A select set of project management best practices to keep your project on-track, on-cost and aligned to scope. Many firms have don't have the necessary skills, diligence, methods and oversight of their projects; this leads to slippage, higher costs and longer timeframes. Often firms have a history of projects that simply failed to move the needle. These best practices will help your firm avoid these pitfalls but they require fortitude to apply.
Creative Web Design Company in Singapore
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Building Your Employer Brand with Social Media
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Recently uploaded (20)
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
Structural Design Process: Step-by-Step Guide for Buildings
Structural Design Process: Step-by-Step Guide for Buildings
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...
Formurex Presentation
- 6. Formulation Development Analytical Services GMP Manufacturing Pre-Formulation Stability Studies
- 11. Direct Compression High Shear Mixing / Granulation
- 12. Dry Granulation / Roller Compaction Dry Granulation / Roller Compaction
- 13. Fluid Bed Processing: Granulation / Drying / Coating Spray Drying
- 14. Nano-Suspensions
- 19. Dissolution Testing & Method Development
- 21. Stability testing for APIs, and formulations at different T/H conditions as per ICH / FDA guidelines
- 26. Thanks!!